NCT06001138View on ClinicalTrials.gov

Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study

Enrolling by invitationOBSERVATIONAL
Enrollment

440

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

September 30, 2029

Study Completion Date

September 30, 2029

Conditions
Multiple Sclerosis
Trial Locations (5)

AB25 2ZD

Aberdeen Clinical Research Facility Royal Cornhill Hospital, Aberdeen

DD1 9SY

Dundee Clinical Research Centre Ninewells Hospital, Dundee

EH16 4SB

Anne Rowling Regenerative Neurology Clinic, Edinburgh

G51 4TF

Glasgow Clinical Research Facility Queen Elizabeth University Hospital, Glasgow

IV2 3JH

Centre for Health Sciences Raigmore Hospital, Inverness

All Listed Sponsors
collaborator

NHS Lothian

OTHER_GOV

lead

University of Edinburgh

OTHER